{"id":8829,"date":"2025-06-21T22:58:54","date_gmt":"2025-06-22T02:58:54","guid":{"rendered":"https:\/\/www.www.www.medicalebooks.org\/?post_type=product&p=8829"},"modified":"2026-04-24T09:04:48","modified_gmt":"2026-04-24T13:04:48","slug":"liver-disease-in-children-5th-edition-original-pdf","status":"publish","type":"product","link":"https:\/\/medicalebooks.org\/uk\/liver-disease-in-children-5th-edition-original-pdf","title":{"rendered":"Liver Disease in Children 5th Edition"},"content":{"rendered":"

Liver Disease in Children 5th Edition-ORIGINAL PDF\u00a0<\/strong><\/h3>\n

Preface
\nIt has been over 25 years since the first edition of Liver Disease
\nin Children was published, and six years have passed since the
\nrelease of the fourth edition. The text continues to be regarded
\nas the premier, comprehensive reference on pediatric liver
\ndisease. There have been groundbreaking advances in our
\nunderstanding of the pathophysiology of liver disease in this
\nage group that have led to improved strategies for diagnosis
\nand treatment. The spectrum, frequency, and nomenclature of
\nliver diseases now encountered in children and adolescents
\nhave significantly changed since the publication of the first
\nedition of this text. For example, Reye syndrome, which war-
\nranted a separate chapter in the first edition, has all but dis-
\nappeared as a significant concern of the pediatric hepatologist.
\nFatty liver disease, which now occupies a significant portion of
\nour clinical practice, was barely recognized as a clinical entity
\nat that time. Inherited cholestatic syndromes involving struc-
\ntural and functional genetic defects of hepatocytes and the
\nbiliary tree were being described, but definition of the under-
\nlying defects required advances in genomics. Genome-wide
\nassociation studies continue to identify susceptibility variants
\nfor disorders including non-alcoholic steatohepatitis, autoim-
\nmune liver disease, viral hepatitis, and biliary atresia and
\nmodifier alleles that can impact on the severity of monogenic
\ndisorders such as alpha-1 antitrypsin deficiency and cystic
\nfibrosis. Various forms of viral hepatitis were clearly defined,
\nbut interferon-based therapies of the time were suboptimal in
\nterms of efficacy and side effects. The scope of advances in this
\narea is best illustrated by the dramatic efficacy of direct acting
\nantivirals for hepatitis C virus infection. There was optimism
\nthat gene therapy could potentially cure several inherited liver
\ndiseases. Although there has been little progress in correcting
\ngenetic defects in the liver, enzyme replacement and identifica-
\ntion of small molecules that can improve gene expression for
\nsome disorders have been significant advances. We continued
\nto wait to define the cause of biliary atresia, but the immuno-
\nbiology of this disorder continues to be elucidated and novel
\nbiomarkers have the potential to more precisely establish an
\nearly diagnosis. The timely evaluation of the cholestatic infant
\nhas usually required a long list of blood tests, imaging, and
\na liver biopsy. Rapid turnaround in gene sequencing now
\nallows a precise diagnosis in a growing number of cases that
\ncan abrogate the need for many of these tests. The revolution in
\ngenomics combined with thorough phenotyping of patients is
\nmaking personalized medicine a reality in pediatric hepatol-
\nogy. Refinements in transplant surgery and immunosuppres-
\nsion continue to improve outcomes for children undergoing
\nliver transplantation.
\nThree internationally known pediatric hepatologists,
\nBenjamin Shneider, Cara Mack, and Jorge Bezerra, have been
\nenlisted as new editors of this fifth edition in order to provide
\nadditional expertise in their areas of interest and to help ensure
\ncontinuity for future editions. Most chapters have been thor-
\noughly revised by previous contributors, but to ensure a fresh
\nperspective and to involve emerging thought leaders, seven
\nchapters have been written by authors contributing to this
\ntextbook for the first time. This fifth edition continues to
\nprovide a critical review of virtually every significant topic in
\npediatric hepatology. Although clinical descriptions may have
\nremained the same over the years, the scientific underpinnings
\nand genetics of many disorders continue to evolve and are
\ncritically reviewed whenever possible. Major advances are
\nemphasized in this text that will impact our ability to make
\na timely diagnosis and to potentially offer effective treatment
\nand potential cures, in some cases for the first time, for infants,
\nchildren, and adolescents with liver disease.
\nFrederick J. Suchy, M.D.
\nRonald J. Sokol, M.D.
\nWilliam F. Balistreri, M.D.
\nBenjamin L. Shneider, M.D.
\nCara L. Mack, M.D.
\nJorge A. Bezerra, M.D.<\/p>\n","protected":false},"excerpt":{"rendered":"

Liver Disease in Children 5th Edition Fifth ed<\/p>\n